Medicare Bill Contains Significant Changes for Drug Manufacturers

The new Medicare bill affects pricing and coverage, revises payment formula, and clarifies generic patent issues.

Related Content:

Regulatory WatchPharmaceutical Technology-01-02-2004

Major Challenges Ahead for FDA and Pharma

FDA Grapples with the Promise and Perils of Gene Therapy

Pandemic Alters Policies and Practices for Drug Development and Regulation